- Home
- PCRX vs MAX Comparison
PCRX vs MAX Comparison
Compare PCRX & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MAX
- Stock Information
- Founded
- PCRX 2006
- MAX 2014
- Country
- PCRX United States
- MAX United States
- Employees
- PCRX N/A
- MAX N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MAX Industrial Machinery/Components
- Sector
- PCRX Health Care
- MAX Industrials
- Exchange
- PCRX Nasdaq
- MAX Nasdaq
- Market Cap
- PCRX 1.2B
- MAX 604.9M
- IPO Year
- PCRX 2011
- MAX 2020
- Fundamental
- Price
- PCRX $26.59
- MAX $11.77
- Analyst Decision
- PCRX Buy
- MAX Buy
- Analyst Count
- PCRX 10
- MAX 8
- Target Price
- PCRX $29.30
- MAX $22.00
- AVG Volume (30 Days)
- PCRX 892.8K
- MAX 375.8K
- Earning Date
- PCRX 02-27-2025
- MAX 02-24-2025
- Dividend Yield
- PCRX N/A
- MAX N/A
- EPS Growth
- PCRX N/A
- MAX N/A
- EPS
- PCRX N/A
- MAX 0.19
- Revenue
- PCRX $694,957,000.00
- MAX $681,230,000.00
- Revenue This Year
- PCRX $5.14
- MAX $122.48
- Revenue Next Year
- PCRX $2.44
- MAX $32.24
- P/E Ratio
- PCRX N/A
- MAX $62.34
- Revenue Growth
- PCRX 4.40
- MAX 72.47
- 52 Week Low
- PCRX $11.16
- MAX $10.21
- 52 Week High
- PCRX $31.67
- MAX $25.78
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- MAX 55.43
- Support Level
- PCRX $25.06
- MAX $11.02
- Resistance Level
- PCRX $27.10
- MAX $11.73
- Average True Range (ATR)
- PCRX 1.45
- MAX 0.45
- MACD
- PCRX 0.28
- MAX 0.09
- Stochastic Oscillator
- PCRX 86.23
- MAX 75.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.